OBJECTIVE
To explore the inhibitory effects and to investigate the mechanisms of combined treatment of osthole, psoralen with aconitine on human breast cancer cell line MDA-MB-231BO.
METHODS
The best inhibitory concentration of osthole, psoralen combined with aconitine on MDA-MB-231BO cells was